M
LLC to enforce MDL discovery agreements on the State of Hawaii in its state court case (In Re: Plavix Marketing, Sales Practices and Products Liability Litigation [No
5 Common Benefit, Time And Expense Rules, Holdback, Assessments and Related Issues I
13-1039 (FLW)(LHG) 2017-06-27
2d 1376
United States Judicial Panel on Feb 12, 2013 · This litigation is before us for a second time
Litig
2300, In re: Plavix Products Liability Litigation
2011) ("Plavix I")
Invokana MDL 2750; J & J Talcum MDL 2738; Plavix MDL 2418; Proton-Pump MDL 2789; Valsartan MDL 2875; American Medical Collection Agency, Inc
See In re: Plavix Prods
That docket involved a total of twelve actions pending in three districts
MDL Cases
II), 923 F
in re: plavix marketing, sales practices and products liability litigation (no
transfer order Docket for IN RE: Plavix Marketing, Sales Practices and Products Liability Litigation (No
R
Invokana MDL 2750; J & J Talcum MDL 2738; Plavix MDL 2418; Proton-Pump MDL 2789; Valsartan MDL 2875; American Medical Collection Agency, Inc
13-cv-2418-FLW-TJB AND MARKETING LITIGATION ALL CASES t4jj] MDL CASE MANAGEMENT ORDER No
Before JOHN G
IN RE: PLAVIX MARKETING, SALES PRACTICES AND PRODUCTS LIABILITY LITIGATION (NO
Invokana MDL 2750; J & J Talcum MDL 2738; Plavix MDL 2418; Proton-Pump MDL 2789; Valsartan MDL 2875; American Medical Collection Agency, Inc
Johnson & Johnson Talcum Powder Litigation
2300, In re: Plavix Products Liability Litigation
2011) ("Plavix I")
MDL Cases
For information on current pending District of New Jersey MDL cases, please click MDL Cases
MDL 2904; Allergan Biocell Textured Breast Implants MDL 2921; Elmiron MDL 2973; Samsung MDL 3055; Insulin Pricing MDL 3080; PACER Center; Transcripts; Vicinage Lines for Case
2418: decision date: 06 june 2013: in re: plavix marketing, sales practices and products liability litigation (no
Invokana MDL 2750; J & J Talcum MDL 2738; Plavix MDL 2418; Proton-Pump MDL 2789; Valsartan MDL 2875; American Medical Collection Agency, Inc
1, plaintiffs in the three actions listed on Schedule A, all of which are pending in the Northern District of California, move to vacate our order conditionally transferring the actions to the District of New Jersey for inclusion in MDL No
1, plaintiffs in the three actions listed on Schedule A, two of which are pending in the Northern District of California, and the other of which TRANSFER ORDER
2418
Filed: February 12, 2013
Invokana MDL 2750; J & J Talcum MDL 2738; Plavix MDL 2418; Proton-Pump MDL 2789; Valsartan MDL 2875; American Medical Collection Agency, Inc
Before the Panel: * Pursuant to Panel Rule 7
MDL 2904; Allergan Biocell Textured Breast Implants MDL 2921; Elmiron MDL 2973; Samsung MDL 3055; Insulin Pricing MDL 3080; PACER Center; Transcripts; Vicinage Lines for Case
II) MDL No
IN RE: PLAVIX MARKETING, SALES PRACTICES AND PRODUCTS LIABILITY LITIGATION (NO
Presiding Judge (s) Hon
M
S